Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1
Status:
Recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
The proposed study is designed to test the hypothesis that treatment of resveratrol for 12
weeks will improve both endothelin-B receptor (aim 1) and skeletal muscle mitochondrial
function (aim 2) in people with type 1 diabetes.